Progressive, refractory, primary intolerance with conventional therapy, recurrent Hemophagocytic Lymphohistiocytosis

DrugDrug NameDrug Description
DB14724EmapalumabAn interferon gamma blocking antibody used to treat primary hemophagocytic lymphohistiocytosis.
DrugDrug NameTargetType
DB14724EmapalumabInterferon gammatarget
DrugDrug NamePhaseStatusCount